[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

COVID-19 Impact on Global Anaesthetic Drugs and Pain Drugs, Market Insights and Forecast to 2026

September 2020 | 111 pages | ID: C07299584C62EN
QYResearch

US$ 3,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Anaesthetic Drugs and Pain Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Anaesthetic Drugs and Pain Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Anaesthetic Drugs and Pain Drugs market is segmented into
  • Anaesthetic Drugs
  • Pain Drugs
Segment by Application, the Anaesthetic Drugs and Pain Drugs market is segmented into
  • Hospital
  • Clinic
Regional and Country-level Analysis
The Anaesthetic Drugs and Pain Drugs market is analysed and market size information is provided by regions (countries).

The key regions covered in the Anaesthetic Drugs and Pain Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Anaesthetic Drugs and Pain Drugs Market Share Analysis
Anaesthetic Drugs and Pain Drugs market competitive landscape provides details and data information by players.
The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Anaesthetic Drugs and Pain Drugs business, the date to enter into the Anaesthetic Drugs and Pain Drugs market, Anaesthetic Drugs and Pain Drugs product introduction, recent developments, etc.

The major vendors covered:
  • AstraZeneca
  • Endo International
  • Johnson & Johnson
  • Pfizer
  • Purdue Pharma
  • Baxter
  • Bayer AG
  • Merck
  • Novartis
1 STUDY COVERAGE

1.1 Anaesthetic Drugs and Pain Drugs Product Introduction
1.2 Market Segments
1.3 Key Anaesthetic Drugs and Pain Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
  1.4.1 Global Anaesthetic Drugs and Pain Drugs Market Size Growth Rate by Type
  1.4.2 Anaesthetic Drugs
  1.4.3 Pain Drugs
1.5 Market by Application
  1.5.1 Global Anaesthetic Drugs and Pain Drugs Market Size Growth Rate by Application
  1.5.2 Hospital
  1.5.3 Clinic
1.6 Coronavirus Disease 2019 (Covid-19): Anaesthetic Drugs and Pain Drugs Industry Impact
  1.6.1 How the Covid-19 is Affecting the Anaesthetic Drugs and Pain Drugs Industry
    1.6.1.1 Anaesthetic Drugs and Pain Drugs Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Anaesthetic Drugs and Pain Drugs Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Anaesthetic Drugs and Pain Drugs Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 EXECUTIVE SUMMARY

2.1 Global Anaesthetic Drugs and Pain Drugs Market Size Estimates and Forecasts
  2.1.1 Global Anaesthetic Drugs and Pain Drugs Revenue 2015-2026
  2.1.2 Global Anaesthetic Drugs and Pain Drugs Sales 2015-2026
2.2 Anaesthetic Drugs and Pain Drugs Market Size by Region: 2020 Versus 2026
  2.2.1 Global Anaesthetic Drugs and Pain Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
  2.2.2 Global Anaesthetic Drugs and Pain Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020

3 GLOBAL ANAESTHETIC DRUGS AND PAIN DRUGS COMPETITOR LANDSCAPE BY PLAYERS

3.1 Anaesthetic Drugs and Pain Drugs Sales by Manufacturers
  3.1.1 Anaesthetic Drugs and Pain Drugs Sales by Manufacturers (2015-2020)
  3.1.2 Anaesthetic Drugs and Pain Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Anaesthetic Drugs and Pain Drugs Revenue by Manufacturers
  3.2.1 Anaesthetic Drugs and Pain Drugs Revenue by Manufacturers (2015-2020)
  3.2.2 Anaesthetic Drugs and Pain Drugs Revenue Share by Manufacturers (2015-2020)
  3.2.3 Global Anaesthetic Drugs and Pain Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
  3.2.4 Global Top 10 and Top 5 Companies by Anaesthetic Drugs and Pain Drugs Revenue in 2019
  3.2.5 Global Anaesthetic Drugs and Pain Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Anaesthetic Drugs and Pain Drugs Price by Manufacturers
3.4 Anaesthetic Drugs and Pain Drugs Manufacturing Base Distribution, Product Types
  3.4.1 Anaesthetic Drugs and Pain Drugs Manufacturers Manufacturing Base Distribution, Headquarters
  3.4.2 Manufacturers Anaesthetic Drugs and Pain Drugs Product Type
  3.4.3 Date of International Manufacturers Enter into Anaesthetic Drugs and Pain Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Anaesthetic Drugs and Pain Drugs Market Size by Type (2015-2020)
  4.1.1 Global Anaesthetic Drugs and Pain Drugs Sales by Type (2015-2020)
  4.1.2 Global Anaesthetic Drugs and Pain Drugs Revenue by Type (2015-2020)
  4.1.3 Anaesthetic Drugs and Pain Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Anaesthetic Drugs and Pain Drugs Market Size Forecast by Type (2021-2026)
  4.2.1 Global Anaesthetic Drugs and Pain Drugs Sales Forecast by Type (2021-2026)
  4.2.2 Global Anaesthetic Drugs and Pain Drugs Revenue Forecast by Type (2021-2026)
  4.2.3 Anaesthetic Drugs and Pain Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Anaesthetic Drugs and Pain Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Anaesthetic Drugs and Pain Drugs Market Size by Application (2015-2020)
  5.1.1 Global Anaesthetic Drugs and Pain Drugs Sales by Application (2015-2020)
  5.1.2 Global Anaesthetic Drugs and Pain Drugs Revenue by Application (2015-2020)
  5.1.3 Anaesthetic Drugs and Pain Drugs Price by Application (2015-2020)
5.2 Anaesthetic Drugs and Pain Drugs Market Size Forecast by Application (2021-2026)
  5.2.1 Global Anaesthetic Drugs and Pain Drugs Sales Forecast by Application (2021-2026)
  5.2.2 Global Anaesthetic Drugs and Pain Drugs Revenue Forecast by Application (2021-2026)
  5.2.3 Global Anaesthetic Drugs and Pain Drugs Price Forecast by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Anaesthetic Drugs and Pain Drugs by Country
  6.1.1 North America Anaesthetic Drugs and Pain Drugs Sales by Country
  6.1.2 North America Anaesthetic Drugs and Pain Drugs Revenue by Country
  6.1.3 U.S.
  6.1.4 Canada
6.2 North America Anaesthetic Drugs and Pain Drugs Market Facts & Figures by Type
6.3 North America Anaesthetic Drugs and Pain Drugs Market Facts & Figures by Application

7 EUROPE

7.1 Europe Anaesthetic Drugs and Pain Drugs by Country
  7.1.1 Europe Anaesthetic Drugs and Pain Drugs Sales by Country
  7.1.2 Europe Anaesthetic Drugs and Pain Drugs Revenue by Country
  7.1.3 Germany
  7.1.4 France
  7.1.5 U.K.
  7.1.6 Italy
  7.1.7 Russia
7.2 Europe Anaesthetic Drugs and Pain Drugs Market Facts & Figures by Type
7.3 Europe Anaesthetic Drugs and Pain Drugs Market Facts & Figures by Application

8 ASIA PACIFIC

8.1 Asia Pacific Anaesthetic Drugs and Pain Drugs by Region
  8.1.1 Asia Pacific Anaesthetic Drugs and Pain Drugs Sales by Region
  8.1.2 Asia Pacific Anaesthetic Drugs and Pain Drugs Revenue by Region
  8.1.3 China
  8.1.4 Japan
  8.1.5 South Korea
  8.1.6 India
  8.1.7 Australia
  8.1.8 Taiwan
  8.1.9 Indonesia
  8.1.10 Thailand
  8.1.11 Malaysia
  8.1.12 Philippines
  8.1.13 Vietnam
8.2 Asia Pacific Anaesthetic Drugs and Pain Drugs Market Facts & Figures by Type
8.3 Asia Pacific Anaesthetic Drugs and Pain Drugs Market Facts & Figures by Application

9 LATIN AMERICA

9.1 Latin America Anaesthetic Drugs and Pain Drugs by Country
  9.1.1 Latin America Anaesthetic Drugs and Pain Drugs Sales by Country
  9.1.2 Latin America Anaesthetic Drugs and Pain Drugs Revenue by Country
  9.1.3 Mexico
  9.1.4 Brazil
  9.1.5 Argentina
9.2 Central & South America Anaesthetic Drugs and Pain Drugs Market Facts & Figures by Type
9.3 Central & South America Anaesthetic Drugs and Pain Drugs Market Facts & Figures by Application

10 MIDDLE EAST AND AFRICA

10.1 Middle East and Africa Anaesthetic Drugs and Pain Drugs by Country
  10.1.1 Middle East and Africa Anaesthetic Drugs and Pain Drugs Sales by Country
  10.1.2 Middle East and Africa Anaesthetic Drugs and Pain Drugs Revenue by Country
  10.1.3 Turkey
  10.1.4 Saudi Arabia
  10.1.5 U.A.E
10.2 Middle East and Africa Anaesthetic Drugs and Pain Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Anaesthetic Drugs and Pain Drugs Market Facts & Figures by Application

11 COMPANY PROFILES

11.1 AstraZeneca
  11.1.1 AstraZeneca Corporation Information
  11.1.2 AstraZeneca Description, Business Overview and Total Revenue
  11.1.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
  11.1.4 AstraZeneca Anaesthetic Drugs and Pain Drugs Products Offered
  11.1.5 AstraZeneca Recent Development
11.2 Endo International
  11.2.1 Endo International Corporation Information
  11.2.2 Endo International Description, Business Overview and Total Revenue
  11.2.3 Endo International Sales, Revenue and Gross Margin (2015-2020)
  11.2.4 Endo International Anaesthetic Drugs and Pain Drugs Products Offered
  11.2.5 Endo International Recent Development
11.3 Johnson & Johnson
  11.3.1 Johnson & Johnson Corporation Information
  11.3.2 Johnson & Johnson Description, Business Overview and Total Revenue
  11.3.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
  11.3.4 Johnson & Johnson Anaesthetic Drugs and Pain Drugs Products Offered
  11.3.5 Johnson & Johnson Recent Development
11.4 Pfizer
  11.4.1 Pfizer Corporation Information
  11.4.2 Pfizer Description, Business Overview and Total Revenue
  11.4.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
  11.4.4 Pfizer Anaesthetic Drugs and Pain Drugs Products Offered
  11.4.5 Pfizer Recent Development
11.5 Purdue Pharma
  11.5.1 Purdue Pharma Corporation Information
  11.5.2 Purdue Pharma Description, Business Overview and Total Revenue
  11.5.3 Purdue Pharma Sales, Revenue and Gross Margin (2015-2020)
  11.5.4 Purdue Pharma Anaesthetic Drugs and Pain Drugs Products Offered
  11.5.5 Purdue Pharma Recent Development
11.6 Baxter
  11.6.1 Baxter Corporation Information
  11.6.2 Baxter Description, Business Overview and Total Revenue
  11.6.3 Baxter Sales, Revenue and Gross Margin (2015-2020)
  11.6.4 Baxter Anaesthetic Drugs and Pain Drugs Products Offered
  11.6.5 Baxter Recent Development
11.7 Bayer AG
  11.7.1 Bayer AG Corporation Information
  11.7.2 Bayer AG Description, Business Overview and Total Revenue
  11.7.3 Bayer AG Sales, Revenue and Gross Margin (2015-2020)
  11.7.4 Bayer AG Anaesthetic Drugs and Pain Drugs Products Offered
  11.7.5 Bayer AG Recent Development
11.8 Merck
  11.8.1 Merck Corporation Information
  11.8.2 Merck Description, Business Overview and Total Revenue
  11.8.3 Merck Sales, Revenue and Gross Margin (2015-2020)
  11.8.4 Merck Anaesthetic Drugs and Pain Drugs Products Offered
  11.8.5 Merck Recent Development
11.9 Novartis
  11.9.1 Novartis Corporation Information
  11.9.2 Novartis Description, Business Overview and Total Revenue
  11.9.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
  11.9.4 Novartis Anaesthetic Drugs and Pain Drugs Products Offered
  11.9.5 Novartis Recent Development
11.1 AstraZeneca
  11.1.1 AstraZeneca Corporation Information
  11.1.2 AstraZeneca Description, Business Overview and Total Revenue
  11.1.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
  11.1.4 AstraZeneca Anaesthetic Drugs and Pain Drugs Products Offered
  11.1.5 AstraZeneca Recent Development

12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)

12.1 Anaesthetic Drugs and Pain Drugs Market Estimates and Projections by Region
  12.1.1 Global Anaesthetic Drugs and Pain Drugs Sales Forecast by Regions 2021-2026
  12.1.2 Global Anaesthetic Drugs and Pain Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Anaesthetic Drugs and Pain Drugs Market Size Forecast (2021-2026)
  12.2.1 North America: Anaesthetic Drugs and Pain Drugs Sales Forecast (2021-2026)
  12.2.2 North America: Anaesthetic Drugs and Pain Drugs Revenue Forecast (2021-2026)
  12.2.3 North America: Anaesthetic Drugs and Pain Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Anaesthetic Drugs and Pain Drugs Market Size Forecast (2021-2026)
  12.3.1 Europe: Anaesthetic Drugs and Pain Drugs Sales Forecast (2021-2026)
  12.3.2 Europe: Anaesthetic Drugs and Pain Drugs Revenue Forecast (2021-2026)
  12.3.3 Europe: Anaesthetic Drugs and Pain Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Anaesthetic Drugs and Pain Drugs Market Size Forecast (2021-2026)
  12.4.1 Asia Pacific: Anaesthetic Drugs and Pain Drugs Sales Forecast (2021-2026)
  12.4.2 Asia Pacific: Anaesthetic Drugs and Pain Drugs Revenue Forecast (2021-2026)
  12.4.3 Asia Pacific: Anaesthetic Drugs and Pain Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Anaesthetic Drugs and Pain Drugs Market Size Forecast (2021-2026)
  12.5.1 Latin America: Anaesthetic Drugs and Pain Drugs Sales Forecast (2021-2026)
  12.5.2 Latin America: Anaesthetic Drugs and Pain Drugs Revenue Forecast (2021-2026)
  12.5.3 Latin America: Anaesthetic Drugs and Pain Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Anaesthetic Drugs and Pain Drugs Market Size Forecast (2021-2026)
  12.6.1 Middle East and Africa: Anaesthetic Drugs and Pain Drugs Sales Forecast (2021-2026)
  12.6.2 Middle East and Africa: Anaesthetic Drugs and Pain Drugs Revenue Forecast (2021-2026)
  12.6.3 Middle East and Africa: Anaesthetic Drugs and Pain Drugs Market Size Forecast by Country (2021-2026)

13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS

13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Anaesthetic Drugs and Pain Drugs Players (Opinion Leaders)

14 VALUE CHAIN AND SALES CHANNELS ANALYSIS

14.1 Value Chain Analysis
14.2 Anaesthetic Drugs and Pain Drugs Customers
14.3 Sales Channels Analysis
  14.3.1 Sales Channels
  14.3.2 Distributors

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Research Methodology
  16.1.1 Methodology/Research Approach
  16.1.2 Data Source
16.2 Author Details
LIST OF TABLES

Table 1. Anaesthetic Drugs and Pain Drugs Market Segments
Table 2. Ranking of Global Top Anaesthetic Drugs and Pain Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Anaesthetic Drugs and Pain Drugs Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Anaesthetic Drugs
Table 5. Major Manufacturers of Pain Drugs
Table 6. COVID-19 Impact Global Market: (Four Anaesthetic Drugs and Pain Drugs Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Anaesthetic Drugs and Pain Drugs Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Anaesthetic Drugs and Pain Drugs Players to Combat Covid-19 Impact
Table 11. Global Anaesthetic Drugs and Pain Drugs Market Size Growth Rate by Application 2020-2026 (K Units)
Table 12. Global Anaesthetic Drugs and Pain Drugs Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 13. Global Anaesthetic Drugs and Pain Drugs Sales by Regions 2015-2020 (K Units)
Table 14. Global Anaesthetic Drugs and Pain Drugs Sales Market Share by Regions (2015-2020)
Table 15. Global Anaesthetic Drugs and Pain Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Anaesthetic Drugs and Pain Drugs Sales by Manufacturers (2015-2020) (K Units)
Table 17. Global Anaesthetic Drugs and Pain Drugs Sales Share by Manufacturers (2015-2020)
Table 18. Global Anaesthetic Drugs and Pain Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Anaesthetic Drugs and Pain Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anaesthetic Drugs and Pain Drugs as of 2019)
Table 20. Anaesthetic Drugs and Pain Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Anaesthetic Drugs and Pain Drugs Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Anaesthetic Drugs and Pain Drugs Price (2015-2020) (USD/Unit)
Table 23. Anaesthetic Drugs and Pain Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Anaesthetic Drugs and Pain Drugs Product Type
Table 25. Date of International Manufacturers Enter into Anaesthetic Drugs and Pain Drugs Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Anaesthetic Drugs and Pain Drugs Sales by Type (2015-2020) (K Units)
Table 28. Global Anaesthetic Drugs and Pain Drugs Sales Share by Type (2015-2020)
Table 29. Global Anaesthetic Drugs and Pain Drugs Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Anaesthetic Drugs and Pain Drugs Revenue Share by Type (2015-2020)
Table 31. Anaesthetic Drugs and Pain Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 32. Global Anaesthetic Drugs and Pain Drugs Sales by Application (2015-2020) (K Units)
Table 33. Global Anaesthetic Drugs and Pain Drugs Sales Share by Application (2015-2020)
Table 34. North America Anaesthetic Drugs and Pain Drugs Sales by Country (2015-2020) (K Units)
Table 35. North America Anaesthetic Drugs and Pain Drugs Sales Market Share by Country (2015-2020)
Table 36. North America Anaesthetic Drugs and Pain Drugs Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Anaesthetic Drugs and Pain Drugs Revenue Market Share by Country (2015-2020)
Table 38. North America Anaesthetic Drugs and Pain Drugs Sales by Type (2015-2020) (K Units)
Table 39. North America Anaesthetic Drugs and Pain Drugs Sales Market Share by Type (2015-2020)
Table 40. North America Anaesthetic Drugs and Pain Drugs Sales by Application (2015-2020) (K Units)
Table 41. North America Anaesthetic Drugs and Pain Drugs Sales Market Share by Application (2015-2020)
Table 42. Europe Anaesthetic Drugs and Pain Drugs Sales by Country (2015-2020) (K Units)
Table 43. Europe Anaesthetic Drugs and Pain Drugs Sales Market Share by Country (2015-2020)
Table 44. Europe Anaesthetic Drugs and Pain Drugs Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Anaesthetic Drugs and Pain Drugs Revenue Market Share by Country (2015-2020)
Table 46. Europe Anaesthetic Drugs and Pain Drugs Sales by Type (2015-2020) (K Units)
Table 47. Europe Anaesthetic Drugs and Pain Drugs Sales Market Share by Type (2015-2020)
Table 48. Europe Anaesthetic Drugs and Pain Drugs Sales by Application (2015-2020) (K Units)
Table 49. Europe Anaesthetic Drugs and Pain Drugs Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Anaesthetic Drugs and Pain Drugs Sales by Region (2015-2020) (K Units)
Table 51. Asia Pacific Anaesthetic Drugs and Pain Drugs Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Anaesthetic Drugs and Pain Drugs Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Anaesthetic Drugs and Pain Drugs Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Anaesthetic Drugs and Pain Drugs Sales by Type (2015-2020) (K Units)
Table 55. Asia Pacific Anaesthetic Drugs and Pain Drugs Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Anaesthetic Drugs and Pain Drugs Sales by Application (2015-2020) (K Units)
Table 57. Asia Pacific Anaesthetic Drugs and Pain Drugs Sales Market Share by Application (2015-2020)
Table 58. Latin America Anaesthetic Drugs and Pain Drugs Sales by Country (2015-2020) (K Units)
Table 59. Latin America Anaesthetic Drugs and Pain Drugs Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Anaesthetic Drugs and Pain Drugs Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Anaesthetic Drugs and Pain Drugs Revenue Market Share by Country (2015-2020)
Table 62. Latin America Anaesthetic Drugs and Pain Drugs Sales by Type (2015-2020) (K Units)
Table 63. Latin America Anaesthetic Drugs and Pain Drugs Sales Market Share by Type (2015-2020)
Table 64. Latin America Anaesthetic Drugs and Pain Drugs Sales by Application (2015-2020) (K Units)
Table 65. Latin America Anaesthetic Drugs and Pain Drugs Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Anaesthetic Drugs and Pain Drugs Sales by Country (2015-2020) (K Units)
Table 67. Middle East and Africa Anaesthetic Drugs and Pain Drugs Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Anaesthetic Drugs and Pain Drugs Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Anaesthetic Drugs and Pain Drugs Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Anaesthetic Drugs and Pain Drugs Sales by Type (2015-2020) (K Units)
Table 71. Middle East and Africa Anaesthetic Drugs and Pain Drugs Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Anaesthetic Drugs and Pain Drugs Sales by Application (2015-2020) (K Units)
Table 73. Middle East and Africa Anaesthetic Drugs and Pain Drugs Sales Market Share by Application (2015-2020)
Table 74. AstraZeneca Corporation Information
Table 75. AstraZeneca Description and Major Businesses
Table 76. AstraZeneca Anaesthetic Drugs and Pain Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. AstraZeneca Product
Table 78. AstraZeneca Recent Development
Table 79. Endo International Corporation Information
Table 80. Endo International Description and Major Businesses
Table 81. Endo International Anaesthetic Drugs and Pain Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Endo International Product
Table 83. Endo International Recent Development
Table 84. Johnson & Johnson Corporation Information
Table 85. Johnson & Johnson Description and Major Businesses
Table 86. Johnson & Johnson Anaesthetic Drugs and Pain Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Johnson & Johnson Product
Table 88. Johnson & Johnson Recent Development
Table 89. Pfizer Corporation Information
Table 90. Pfizer Description and Major Businesses
Table 91. Pfizer Anaesthetic Drugs and Pain Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Pfizer Product
Table 93. Pfizer Recent Development
Table 94. Purdue Pharma Corporation Information
Table 95. Purdue Pharma Description and Major Businesses
Table 96. Purdue Pharma Anaesthetic Drugs and Pain Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Purdue Pharma Product
Table 98. Purdue Pharma Recent Development
Table 99. Baxter Corporation Information
Table 100. Baxter Description and Major Businesses
Table 101. Baxter Anaesthetic Drugs and Pain Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Baxter Product
Table 103. Baxter Recent Development
Table 104. Bayer AG Corporation Information
Table 105. Bayer AG Description and Major Businesses
Table 106. Bayer AG Anaesthetic Drugs and Pain Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. Bayer AG Product
Table 108. Bayer AG Recent Development
Table 109. Merck Corporation Information
Table 110. Merck Description and Major Businesses
Table 111. Merck Anaesthetic Drugs and Pain Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Merck Product
Table 113. Merck Recent Development
Table 114. Novartis Corporation Information
Table 115. Novartis Description and Major Businesses
Table 116. Novartis Anaesthetic Drugs and Pain Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Novartis Product
Table 118. Novartis Recent Development
Table 119. Global Anaesthetic Drugs and Pain Drugs Sales Forecast by Regions (2021-2026) (K Units)
Table 120. Global Anaesthetic Drugs and Pain Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 121. Global Anaesthetic Drugs and Pain Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 122. Global Anaesthetic Drugs and Pain Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 123. North America: Anaesthetic Drugs and Pain Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 124. North America: Anaesthetic Drugs and Pain Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 125. Europe: Anaesthetic Drugs and Pain Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 126. Europe: Anaesthetic Drugs and Pain Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 127. Asia Pacific: Anaesthetic Drugs and Pain Drugs Sales Forecast by Region (2021-2026) (K Units)
Table 128. Asia Pacific: Anaesthetic Drugs and Pain Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 129. Latin America: Anaesthetic Drugs and Pain Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 130. Latin America: Anaesthetic Drugs and Pain Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 131. Middle East and Africa: Anaesthetic Drugs and Pain Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 132. Middle East and Africa: Anaesthetic Drugs and Pain Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 133. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 134. Key Challenges
Table 135. Market Risks
Table 136. Main Points Interviewed from Key Anaesthetic Drugs and Pain Drugs Players
Table 137. Anaesthetic Drugs and Pain Drugs Customers List
Table 138. Anaesthetic Drugs and Pain Drugs Distributors List
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources

LIST OF FIGURES

Figure 1. Anaesthetic Drugs and Pain Drugs Product Picture
Figure 2. Global Anaesthetic Drugs and Pain Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Anaesthetic Drugs Product Picture
Figure 4. Pain Drugs Product Picture
Figure 5. Global Anaesthetic Drugs and Pain Drugs Sales Market Share by Application in 2020 & 2026
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Anaesthetic Drugs and Pain Drugs Report Years Considered
Figure 9. Global Anaesthetic Drugs and Pain Drugs Market Size 2015-2026 (US$ Million)
Figure 10. Global Anaesthetic Drugs and Pain Drugs Sales 2015-2026 (K Units)
Figure 11. Global Anaesthetic Drugs and Pain Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Global Anaesthetic Drugs and Pain Drugs Sales Market Share by Region (2015-2020)
Figure 13. Global Anaesthetic Drugs and Pain Drugs Sales Market Share by Region in 2019
Figure 14. Global Anaesthetic Drugs and Pain Drugs Revenue Market Share by Region (2015-2020)
Figure 15. Global Anaesthetic Drugs and Pain Drugs Revenue Market Share by Region in 2019
Figure 16. Global Anaesthetic Drugs and Pain Drugs Sales Share by Manufacturer in 2019
Figure 17. The Top 10 and 5 Players Market Share by Anaesthetic Drugs and Pain Drugs Revenue in 2019
Figure 18. Anaesthetic Drugs and Pain Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Anaesthetic Drugs and Pain Drugs Sales Market Share by Type (2015-2020)
Figure 20. Global Anaesthetic Drugs and Pain Drugs Sales Market Share by Type in 2019
Figure 21. Global Anaesthetic Drugs and Pain Drugs Revenue Market Share by Type (2015-2020)
Figure 22. Global Anaesthetic Drugs and Pain Drugs Revenue Market Share by Type in 2019
Figure 23. Global Anaesthetic Drugs and Pain Drugs Market Share by Price Range (2015-2020)
Figure 24. Global Anaesthetic Drugs and Pain Drugs Sales Market Share by Application (2015-2020)
Figure 25. Global Anaesthetic Drugs and Pain Drugs Sales Market Share by Application in 2019
Figure 26. Global Anaesthetic Drugs and Pain Drugs Revenue Market Share by Application (2015-2020)
Figure 27. Global Anaesthetic Drugs and Pain Drugs Revenue Market Share by Application in 2019
Figure 28. North America Anaesthetic Drugs and Pain Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 29. North America Anaesthetic Drugs and Pain Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 30. North America Anaesthetic Drugs and Pain Drugs Sales Market Share by Country in 2019
Figure 31. North America Anaesthetic Drugs and Pain Drugs Revenue Market Share by Country in 2019
Figure 32. U.S. Anaesthetic Drugs and Pain Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 33. U.S. Anaesthetic Drugs and Pain Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Canada Anaesthetic Drugs and Pain Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 35. Canada Anaesthetic Drugs and Pain Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. North America Anaesthetic Drugs and Pain Drugs Market Share by Type in 2019
Figure 37. North America Anaesthetic Drugs and Pain Drugs Market Share by Application in 2019
Figure 38. Europe Anaesthetic Drugs and Pain Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 39. Europe Anaesthetic Drugs and Pain Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. Europe Anaesthetic Drugs and Pain Drugs Sales Market Share by Country in 2019
Figure 41. Europe Anaesthetic Drugs and Pain Drugs Revenue Market Share by Country in 2019
Figure 42. Germany Anaesthetic Drugs and Pain Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 43. Germany Anaesthetic Drugs and Pain Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. France Anaesthetic Drugs and Pain Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 45. France Anaesthetic Drugs and Pain Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. U.K. Anaesthetic Drugs and Pain Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 47. U.K. Anaesthetic Drugs and Pain Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Italy Anaesthetic Drugs and Pain Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 49. Italy Anaesthetic Drugs and Pain Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Russia Anaesthetic Drugs and Pain Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 51. Russia Anaesthetic Drugs and Pain Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Europe Anaesthetic Drugs and Pain Drugs Market Share by Type in 2019
Figure 53. Europe Anaesthetic Drugs and Pain Drugs Market Share by Application in 2019
Figure 54. Asia Pacific Anaesthetic Drugs and Pain Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 55. Asia Pacific Anaesthetic Drugs and Pain Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 56. Asia Pacific Anaesthetic Drugs and Pain Drugs Sales Market Share by Region in 2019
Figure 57. Asia Pacific Anaesthetic Drugs and Pain Drugs Revenue Market Share by Region in 2019
Figure 58. China Anaesthetic Drugs and Pain Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 59. China Anaesthetic Drugs and Pain Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Japan Anaesthetic Drugs and Pain Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 61. Japan Anaesthetic Drugs and Pain Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. South Korea Anaesthetic Drugs and Pain Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 63. South Korea Anaesthetic Drugs and Pain Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. India Anaesthetic Drugs and Pain Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 65. India Anaesthetic Drugs and Pain Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Australia Anaesthetic Drugs and Pain Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 67. Australia Anaesthetic Drugs and Pain Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Taiwan Anaesthetic Drugs and Pain Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 69. Taiwan Anaesthetic Drugs and Pain Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Indonesia Anaesthetic Drugs and Pain Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 71. Indonesia Anaesthetic Drugs and Pain Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Thailand Anaesthetic Drugs and Pain Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 73. Thailand Anaesthetic Drugs and Pain Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Malaysia Anaesthetic Drugs and Pain Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 75. Malaysia Anaesthetic Drugs and Pain Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Philippines Anaesthetic Drugs and Pain Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 77. Philippines Anaesthetic Drugs and Pain Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Vietnam Anaesthetic Drugs and Pain Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 79. Vietnam Anaesthetic Drugs and Pain Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Asia Pacific Anaesthetic Drugs and Pain Drugs Market Share by Type in 2019
Figure 81. Asia Pacific Anaesthetic Drugs and Pain Drugs Market Share by Application in 2019
Figure 82. Latin America Anaesthetic Drugs and Pain Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 83. Latin America Anaesthetic Drugs and Pain Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 84. Latin America Anaesthetic Drugs and Pain Drugs Sales Market Share by Country in 2019
Figure 85. Latin America Anaesthetic Drugs and Pain Drugs Revenue Market Share by Country in 2019
Figure 86. Mexico Anaesthetic Drugs and Pain Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 87. Mexico Anaesthetic Drugs and Pain Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Brazil Anaesthetic Drugs and Pain Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 89. Brazil Anaesthetic Drugs and Pain Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Argentina Anaesthetic Drugs and Pain Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 91. Argentina Anaesthetic Drugs and Pain Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Latin America Anaesthetic Drugs and Pain Drugs Market Share by Type in 2019
Figure 93. Latin America Anaesthetic Drugs and Pain Drugs Market Share by Application in 2019
Figure 94. Middle East and Africa Anaesthetic Drugs and Pain Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 95. Middle East and Africa Anaesthetic Drugs and Pain Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 96. Middle East and Africa Anaesthetic Drugs and Pain Drugs Sales Market Share by Country in 2019
Figure 97. Middle East and Africa Anaesthetic Drugs and Pain Drugs Revenue Market Share by Country in 2019
Figure 98. Turkey Anaesthetic Drugs and Pain Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 99. Turkey Anaesthetic Drugs and Pain Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Saudi Arabia Anaesthetic Drugs and Pain Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 101. Saudi Arabia Anaesthetic Drugs and Pain Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. U.A.E Anaesthetic Drugs and Pain Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 103. U.A.E Anaesthetic Drugs and Pain Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Middle East and Africa Anaesthetic Drugs and Pain Drugs Market Share by Type in 2019
Figure 105. Middle East and Africa Anaesthetic Drugs and Pain Drugs Market Share by Application in 2019
Figure 106. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 107. Endo International Total Revenue (US$ Million): 2019 Compared with 2018
Figure 108. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Purdue Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Baxter Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Bayer AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. North America Anaesthetic Drugs and Pain Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 116. North America Anaesthetic Drugs and Pain Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Europe Anaesthetic Drugs and Pain Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 118. Europe Anaesthetic Drugs and Pain Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Asia Pacific Anaesthetic Drugs and Pain Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 120. Asia Pacific Anaesthetic Drugs and Pain Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Latin America Anaesthetic Drugs and Pain Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 122. Latin America Anaesthetic Drugs and Pain Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Middle East and Africa Anaesthetic Drugs and Pain Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 124. Middle East and Africa Anaesthetic Drugs and Pain Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Porter's Five Forces Analysis
Figure 126. Channels of Distribution
Figure 127. Distributors Profiles
Figure 128. Bottom-up and Top-down Approaches for This Report
Figure 129. Data Triangulation
Figure 130. Key Executives Interviewed


More Publications